𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycosis fungoides d'emblée: A rare presentation of cutaneous T-cell lymphoma

✍ Scribed by Lawrence G. Blasik; Russell E. Newkirk; Robert L. Dimond; William E. Clendenning

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
800 KB
Volume
49
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of Epstein-Barr virus in cuta
Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides
✍ Misuzu Shimakage; Toshiyuki Sasagawa; Kunimitsu Kawahara; Masuo Yutsudo; Hideo K 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 750 KB

Cutaneous T-Cell lymphoma (CTCL) is a non-Hodgkin's lymphoma of unknown pathogenesis. Mycosis fungoides (MF) is a clinically determined subset of CTCL with intensive infiltration of lymphoma cells into the epidermis. To determine whether Epstein-Barr virus (EBV) is associated with these lymphoma cel

Total skin electron radiation for patien
Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome)
✍ Glenn W. Jones; Donald Rosenthal; Lynn D. Wilson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## BACKGROUND. There is limited published evidence regarding the efficacy of total skin electron beam radiation for patients with the diffuse erythrodermic form of mycosis fungoides. ## METHODS. Forty-five patients with erythrodermic mycosis fungoides were managed at McMaster University in Hamilt

Expression and activity of IL-17 in cuta
Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and sezary syndrome)
✍ Arnaud Cirée; Laurence Michel; Sophie Camilleri-Bröet; Francette Jean Louis; Mic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 412 KB 👁 1 views

## Abstract Interleukin‐17 (IL‐17) is a proinflammatory cytokine mainly produced by activated CD4^+^ CD45RO T cells. In mice, we have demonstrated that, depending on the model, IL‐17 may act as a tumor growth‐promoting or ‐inhibiting factor. In order to address the relevance of these models in huma